Swiss pharmaceutical giant Novartis cautioned its core operating income could fall by a low single digit percentage this year due to heavy investment in its new heart-failure drug Entresto.
from WSJ.com: US Business http://ift.tt/2a4qVIe
via IFTTT
No comments:
Post a Comment